Drug Development Tools Research Grants (U01) Clinical Trials Optional

The summary for the Drug Development Tools Research Grants (U01) Clinical Trials Optional grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.

Drug Development Tools Research Grants (U01) Clinical Trials Optional: The purpose of this funding opportunity announcement (FOA) is to support research to continue the development of drug development tools that have an accepted or a reviewable Letter of Intent (LOI) within a drug development tool qualification program within either CBER or CDER. The grants will be used to further the development of tools that, once qualified, will be made publicly available to fill unmet needs in drug development.

Federal Grant Title:	Drug Development Tools Research Grants (U01) Clinical Trials Optional
Federal Agency Name:	Food and Drug Administration (HHS-FDA)
Grant Categories:	Agriculture, Consumer Protection, Food and Nutrition
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-FD-24-030
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.103
CFDA Descriptions:	Information not provided
Current Application Deadline:	May 13th, 2025
Original Application Deadline:	May 13th, 2025
Posted Date:	February 12th, 2024
Creation Date:	February 12th, 2024
Archive Date:	June 12th, 2025
Total Program Funding:	$6
Maximum Federal Grant Award:	$500,000
Minimum Federal Grant Award:	$500,000
Expected Number of Awards:	6
Cost Sharing or Matching:	No
Last Updated:	February 6th, 2024

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: These grants will be used to provide funding to developers of drug development tools that have an accepted or a reviewable Letter of Intent (LOI) within a CDER/CBER's Drug Development Tool Qualification Program and are working towards their qualification plan (QP) or full qualification package (FQP). If you received DDT research grant support from FDA-CDER/CBER in previous years, you are eligible to apply provided that you have successfully progressed to the next submission milestone (e.g., Accepted LOI to Accepted QP) and are requesting additional funding for new DDT project needs addressing different aspects of the project.
Grant Announcement Contact: Terrin Brown
Grantor
Phone 2404027610
[email protected]
Similar Government Grants: • Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional; • Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinic...; • Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, a...; • Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical...; • Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biologic...; • Support for Small Scientific Conference Grant Program; • Cooperative Agreement to Support the World Health Organization (WHO) International Program...; • Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the Food and Drug Administration: • Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional; • Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinic...; • Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, a...